Perioperative Ketoacidosis with SGLT-2 Inhibitors: More Lessons to Learn
Rohan Magoon, Varun Suresh
Citation Information :
Magoon R, Suresh V. Perioperative Ketoacidosis with SGLT-2 Inhibitors: More Lessons to Learn. Res Inno Anesth 2023; 8 (2):66-66.
Kela MM. Dapagliflozin causing euglycemic diabetic ketoacidosis. J Res and Innov Anesth 2023;8(1):11–12. DOI: 10.5005/jp-journals-10049-2020
Magoon R, Jose J. A word-of-caution against euglycaemic DKA! Turk J Anaesthesiol Reanim 2022;50(6):469–470. DOI: 10.5152/TJAR.2022.21144
Seki H, Watanabe H, Yorozu T. Postoperative ketoacidosis with hypoglycemia in a nondiabetic patient taking dapagliflozin for heart failure: a case report. A A Pract 2022;16(3):e01570. DOI: 10.1213/XAA.0000000000001570
The EMPA-KIDNEY Collaborative Group, Herrington WG, Staplin N, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med 2023;388(2):117–127. DOI: 10.1056/NEJMoa2204233